Targeting abundant survivin expression in liposarcoma: subtype dependent therapy responses to YM155 treatment

PURPOSE: Liposarcoma (LPS) represent the largest group of malignant soft tissue tumours comprising a heterogeneous group of subtypes in which the degrees of chemoresistance and radiosensitivity strongly vary. Consequently, it is of utmost interest to establish novel therapeutic regimens based on mol...

Descripción completa

Detalles Bibliográficos
Autores principales: Vay, Christian, Schlünder, Philipp M., Dizdar, Levent, Esposito, Irene, Ghadimi, Markus P. H., Knoefel, Wolfram T., Krieg, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article – Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881260/
https://www.ncbi.nlm.nih.gov/pubmed/34860309
http://dx.doi.org/10.1007/s00432-021-03871-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881260/
https://www.ncbi.nlm.nih.gov/pubmed/34860309
http://dx.doi.org/10.1007/s00432-021-03871-5

Ejemplares similares